ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Breast Cancer Patients Track Symptoms With Digital Device

September 25, 2009

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

Neutron Answers Needed Soon, Kligerman Says

May 6, 1983